IL-6 levels were significantly reduced in obese individuals, particularly with longer treatment durations and synbiotic interventions, while TNF-α reductions were most pronounced in long-term interventions (≥12 weeks), especially among T2DM patients with normal BMI and when probiotics were used. Here, IL6 is linked to type 2 diabetes mellitus.